Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06453083 · ClinicalTrials.gov registry record · Early Phase 1
Medrol Dose Packs for Post-Operative Pain Control
A Early Phase 1 study of Pain, sponsored by University of Utah.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 57
- Enrollment target
- 1
- Study location
NCT06453083: Completed Early Phase 1 study of Pain, sponsored by University of Utah.
NCT06453083 is a Early Phase 1 study of Pain that has completed, run by University of Utah. The registered enrollment target is 57 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06453083, a Early Phase 1 study of Pain, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 57 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators primary purpose of this study is to determine if the addition of a short course use of steroids following surgery for Adolescent Idiopathic Scoliosis (AIS) will improve post-operative pain management and shorten hospital length of stay.
Primary Outcome
VAS pain score (0 no pain - 10 severe pain)
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Medrol
Study Locations (1)
Utah
- University of Utah Orthopaedic Center - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2023-01-13 |
| Est. Completion | 2024-12-17 |
| Phase | Early Phase 1 |
What the finished NCT06453083 record still lists
NCT06453083 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06453083 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT06453083 about?
NCT06453083 is a clinical study titled "Medrol Dose Packs for Post-Operative Pain Control". The investigators primary purpose of this study is to determine if the addition of a short course use of steroids following surgery for Adolescent Idiopathic Scoliosis (AIS) will improve post-operative pain management and shorten hospital length of stay.
What is the current status of trial NCT06453083?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 57 participants. The study started on 2023-01-13. Estimated completion is 2024-12-17.
What conditions does trial NCT06453083 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT06453083?
The interventions under investigation include: Placebo (DRUG), Medrol (DRUG).
Who is sponsoring clinical trial NCT06453083?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06453083 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06453083's enrollment target sits among peer trials
57 244th of 374 higher than 131 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Opioid-Sparing and Pain-Reducing Properties of Syntocinon: A Dose-Effect Determination
RECRUITING · Early Phase 1
-
The Potential of Oxytocin to Reduce Opioid Abuse Liability and Pain Among Older Adults
RECRUITING · Early Phase 1
-
Effects of Dronabinol in Opioid Maintained Patients
RECRUITING · Early Phase 1
-
Remimazolam NeuroImaging
RECRUITING · Early Phase 1
-
Nitrous Oxide Neuroimaging
RECRUITING · Early Phase 1
-
Ketamine and Propofol NeuroImaging
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI